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Introduction {#sec1}
============

Repair of DNA double-strand breaks (DSBs) is essential for maintaining genomic integrity and cell survival. Chromatin remodeling factors are key components of the DNA DSB repair process since repair takes place within a dynamic chromatin context, and several ATP-dependent chromatin remodeling factors have been implicated in DNA repair pathways including the homologous recombination (HR), non-homologous end joining (NHEJ), and nuclear excision pathways ([@bib9], [@bib12], [@bib15], [@bib18], [@bib20], [@bib22], [@bib25], [@bib27], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib43], [@bib48]).

The SMARCAD1 protein is a member of the SNF2 helicase subfamily and the SWI/SNF family of ATPase containing DEAD/H box helicase domain proteins ([@bib1]). The ATP-dependent SWI/SNF family members are critical for DNA replication and HR ([@bib7], [@bib26], [@bib42]). SMARCAD1 also functions in the propagation and organization of epigenetic patterns following DNA replication ([@bib35]) as well as in heterochromatin maintenance and inheritance ([@bib40]). Functionally, SMARCAD1 is involved in the regulation of global histone acetylation with a suggested role in histone deacetylation by interacting with HDAC1 during replication ([@bib14], [@bib35]). SMARCAD1 is also recruited to newly synthesized DNA and facilitates histone deacetylation, histone H3K9 trimethylation (H3K9me3), and efficient HP1 recruitment through a mechanism coupled to ATP hydrolysis ([@bib35]). Previously it has been shown by immunofluorescence co-staining of SMARCAD1 and γ−H2AX along laser micro-irradiation tracks that SMARCAD1 localizes to the vicinity of DSB sites ([@bib8]). Moreover, SMARCAD1 was suggested to have a role in DNA end resection because RPA foci formation in depleted cells was decreased. The timing of SMARCAD1 function appears to be early during repair because it has been reported that SMARCAD1 binds to H2A-Ub at the DNA damage sites and is required for 53BP1 repositioning after BRCA1 recruitment ([@bib10]). A proteomics survey of ionizing radiation (IR)-induced phosphopeptides identified SMARCAD1 as a possible ATM substrate with potential sites at S132 and S302 ([@bib23]). However, further confirmation of these sites or their biological function has not been reported but does suggest potential SMARCAD1 coupling to IR-induced ATM activity.

Further details about the mechanism and functional significance of SMARCAD1 regulation during DNA repair are limited. In this study, we identified two previously unknown post-translational SMARCAD1 modifications, ATM-mediated phosphorylation of Thr906 (T906) and ubiquitination of Lys905 (K905) by RING1, which are critical steps required for subsequent binding of DNA repair factors and healing of DNA lesions. Depletion of SMARCAD1 or loss of these post-translational modifications decreased DNA end resection, reduced DNA DSB repair by HR, and increased IR-induced chromosome damage and cell death.

Results {#sec2}
=======

SMARCAD1 Localizes to DSBs Preferentially during S-Phase {#sec2.1}
--------------------------------------------------------

SMARCAD1 has been implicated in DNA resection, a critical step in homologous-recombination-mediated DNA DSB repair, which primarily occurs during the cell cycle S-phase. Therefore we measured SMARCAD1 recruitment to a DSB site during the cell cycle, before and after induction of the DSB, by chromatin immunoprecipitation (ChIP)/PCR using specific primers at different distances from a defined l-Scel-induced DSB. Exponentially growing cells were enriched in G1-, S-, or G2/M-phase as described previously ([@bib13], [@bib34]), induced for l-Scel site cleavage, and analyzed by ChIP for γ-H2AX, KU80, RAD51, and SMARCAD1. As expected, exponentially growing cells showed recruitment of SMARCAD1 as well as γ-H2AX, KU80, and RAD51 to the DSB produced by l-Scel cleavage ([Figure 1](#fig1){ref-type="fig"}A). Irrespective of the cell phase, the surrogate DSB marker γ-H2AX was largely recruited to the l-Scel DNA site only after break induction ([Figures 1](#fig1){ref-type="fig"}B--1D). In G1-phase cells, increased localization of KU80 was observed, whereas levels of RAD51 and SMARCAD1 at the break site were significantly less ([Figure 1](#fig1){ref-type="fig"}B). Conversely, significant recruitment of RAD51 and SMARCAD1 was observed in S-phase cells, whereas KU80 levels were relatively lower ([Figure 1](#fig1){ref-type="fig"}C). In G2/M-phase cells, the levels of SMARCAD1 were once again low when compared with the KU80 levels, which were significantly greater ([Figure 1](#fig1){ref-type="fig"}D). Therefore SMARCAD1 is recruited to DSBs predominantly during the S-phase, and the results are similar to those of the known HR repair component RAD51. Interestingly, there were no differences in cell cycle distribution between control small interfering RNA (siRNA)-transfected cells (G1 57.36%, S 23.56%, G2 19.08%) and SMARCAD1-depleted cells (G1 54.87%, S 26.45%, and G2 20.67%), suggesting that SMARCAD1 depletion does not interfere with the cell cycle status in the absence of damage.Figure 1Recruitment of Repair Proteins at DSBSMARCAD1 is recruited to DSB site: Detection of repair proteins by ChIP at I-SceI site before and after induction of DSB. Cell synchronization, cell cycle analysis, I-SceI-induced DSB, and ChIP analysis were done according to the described procedure ([@bib13], [@bib34]). The closest PCR products to the l-Scel-induced DSB site are 94--378, 675--1044, and 901--1210 (away from the I-SceI-induced break site).(A--D) (A) Exponential phase cells, (B) G1-phase cells, (C) S-phase cells, and (D) G2/M-phase cells.

SMARCAD1 Depletion Decreases IR-Induced Foci Formation by Proteins Involved in DSB Repair by Homologous Recombination {#sec2.2}
---------------------------------------------------------------------------------------------------------------------

To determine the impact of SMARCAD1 on repairosome kinetics, we examined IR-induced γ-H2AX, 53BP1, BRCA1, RPA, and RAD51 foci formation by immunofluorescent staining of cells with and without SMARCAD1 depletion ([Figure 2](#fig2){ref-type="fig"}). Depletion of SMARCAD1 increased the frequency of irradiated cells with residual γ-H2AX ([Figures 2](#fig2){ref-type="fig"}A and 2B) and 53BP1 foci ([Figures 2](#fig2){ref-type="fig"}C and 2D), whereas the number of cells with BRCA1 ([Figures 2](#fig2){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}C), RPA ([Figures 2](#fig2){ref-type="fig"}F and [S1](#mmc1){ref-type="supplementary-material"}B), and RAD51 ([Figures 2](#fig2){ref-type="fig"}G and 2H) foci was significantly reduced, without any change in the overall cellular levels of BRCA1, RPA, or RAD51 protein ([Figures S1](#mmc1){ref-type="supplementary-material"}D, S1E, S1F, and S1G).Figure 2Immunofluorescence Measurement of Repairosome Foci FormationSMARCAD1 depletion affects repairosome formation: (A) immunofluorescent visualization of γ-H2AX at different time points after 2 Gy irradiation.(B) Quantification of cells for IR-induced foci formation with, and without, SMARCAD1 depletion.(C) Immunofluorescent visualization of 53BP1 at different time points after 5 Gy irradiation.(D) Quantification of cells for IR-induced foci formation with, and without, SMARCAD1 depletion.(E) Quantification of cells for IR-induced BRCA1 foci formation with, and without, SMARCAD1 depletion.(F) Quantification of cells for IR-induced RPA foci formation with, and without, SMARCAD1 depletion.(G) Immunofluorescent visualization of RAD51 at different time points after 5 Gy irradiation.(H) Quantification of cells for IR-induced RAD51 foci formation with, and without, SMARCAD1 depletion.For cells with foci, at least 100 cells were examined, and the mean presented is from three to four experiments (\*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001 as determined by Student\'s t test).

The 53BP1 and BRCA1 balance at a DSB site determines the repair pathway choice, and SMARCAD1 depletion appeared to impede/delay 53BP1 removal from damage sites ([Figures 2](#fig2){ref-type="fig"}C and 2D) while correspondingly decreasing/delaying BRCA1 recruitment ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Immunofluorescence co-localization studies demonstrated that 53BP1/BRCA1 foci were present in control cells at 120 min post-irradiation, but by 240 min, there was little foci overlap and most of the 53BP1 signal had dispersed. Depletion of SMARCAD1 led to mainly 53BP1 foci being present, with occasional 53BP1/BRCA1 co-foci, at 120 min post-irradiation ([Figure S1](#mmc1){ref-type="supplementary-material"}H). At 240 min, there were still 53BP1 foci present, but limited co-localization of BRCA1/53BP1 foci were detected ([Figure S1](#mmc1){ref-type="supplementary-material"}H). These results are consistent with a model in which SMARCAD1 facilitates BRCA1 displacement of 53BP1 from DSB sites ([@bib10]) to further HR-mediated repair.

SMARCAD1 Recruitment at DNA DSBs Is ATM Dependent {#sec2.3}
-------------------------------------------------

Eukaryotic cells respond to DNA damage with a rapid activation of the ATM/ATR protein kinase signaling cascade to induce cell cycle arrest and activate the checkpoint kinases required to maintain genome integrity ([@bib19], [@bib37], [@bib38]). To determine the impact of ATM or ATR inactivation on the recruitment of SMARCAD1 at DSBs, cells were treated with an inhibitor of ATM (KU55933) or ATR (VE-821) and then examined for SMARCAD1 DSB recruitment by ChIP, as described above. Exponential phase cells treated with ATM inhibitor had a significant decrease of SMARCAD1 association with the DSB, whereas no impact was observed in cells treated with ATR ([Figure 3](#fig3){ref-type="fig"}A). The decrease in SMARCAD1 association with DSB was maximum in S-phase cells after ATM inhibitor treatment, whereas ATR had no effect, suggesting that ATM-dependent modification(s) may be required for the association of SMARCAD1 with the DNA DSBs ([Figures 3](#fig3){ref-type="fig"}B, 3C, and 3D).Figure 3Impact of SMARCAD1 on ResectionSMARCAD1 phosphorylation is critical for DNA end resection: (A--D) effect of ATM inhibitor KU55933 or ATR inhibitor on SMARCAD1 recruitment at DSB in cells growing in exponential phase (A), G1-phase (B), S-phase (C), and G2/M-phase (D). Note that cells in S-phase have reduced amount of SMARCAD1 associated with DSB.(E) Western blot showing phosphorylation of SMARCAD1 after cells are exposed to 10 Gy ionizing radiation.(F and G) Schematic diagram of ER-AsiSI DNA end resection assay based on ChIP/qPCR quantitation of ssDNA (F), and 4-Hydroxytamoxifen (OHT) inducible as visualization by immunofluorescence (G).(H) Western blot showing MRE11 depletion by specific siRNA.(I) SMARCAD1 depletion or expression of the T906A, T906E, and K528R mutations decreases ssDNA formation. MRE11 depletion is a positive control for the resection assay. DNA resection assay was performed in U2OS cells using qPCR.The mean presented is from three to four experiments (\*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001, \*\*\*\*p \< 0.0005 as determined by Student\'s t test).

IR activates ATM ([@bib2], [@bib28]), which then phosphorylates specific SQ/TQ sites on downstream DNA damage signaling/repair effector proteins ([@bib23]). SMARCAD1 has multiple SQ motifs and one TQ motif, the core consensus sequence sites phosphorylated by ATM/ATR ([@bib3], [@bib23]). Phosphorylation was further confirmed by western blot analysis of SMARCAD1 immunoprecipitates from cell extracts with a phospho-SQ/TQ antibody, which detected IR-induced phosphorylation within 30 min post-irradiation ([Figure 3](#fig3){ref-type="fig"}E).

SMARCAD1 T906 Phosphorylation Is a Prerequisite for Efficient DNA End Resection {#sec2.4}
-------------------------------------------------------------------------------

Based on our observations that SMARCAD1 had only one potential ATM TQ site and that it was conserved in higher vertebrates, including humans ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B), the single SMARCAD1 TQ (T^906^Q^907^) motif was mutated (T906A and T906E) and the effect of mutations on resection was determined in cells depleted of endogenous SMARCAD1 ([Figures S2](#mmc1){ref-type="supplementary-material"}C, S2D, and S2E). Resection was measured as ssDNA production at 0.3, 1.6, and 3.5 kb from an AsiSI DNA cleavage site in SMARCAD1-depleted cells by using a previously described technique ([@bib47]) ([Figures 3](#fig3){ref-type="fig"}F and 3G). Consistent with a major role for SMARCAD1 in resection, we found that ssDNA levels at all distances from the DSB were decreased upon SMARCAD1 depletion, which are results similar to that produced by MRE11 nuclease depletion ([Figures 3](#fig3){ref-type="fig"}H and 3I). The reduction in DNA resection after endogenous SMARCAD1 depletion could not be rescued by SMARCAD1-T906A expression but was rescued by the phospho-mimetic T906E mutant ([Figure 3](#fig3){ref-type="fig"}I), confirming the importance of ATM-mediated SMARCAD1 phosphorylation in resection. Likewise, resection after SMARCAD1 depletion was not rescued by expression of the ATPase mutant K528R, suggesting that the ATPase activity of SMARCAD1 is also required during DNA end resection ([Figure 3](#fig3){ref-type="fig"}I).

Ionizing Radiation-Induced SMARCAD1 Ubiquitination by RING1 {#sec2.5}
-----------------------------------------------------------

The interplay between post-translational phosphorylation and ubiquitination has emerged as an important means of regulation in eukaryotic cell signaling pathways ([@bib16]) where phosphorylation can serve as a marker to trigger ubiquitination ([@bib11], [@bib21], [@bib41]). Ubiquitination itself can provide a switching mechanism to turn kinases on or off ([@bib45]) as well as provide interaction sites for additional regulatory proteins that contain ubiquitin-binding domains (UBDs). SMARCAD1 contains two N-terminal CUE domains (CUE1, CUE2), which are equivalent to UBD. Such UBDs are often key regulators in mediating protein/protein interaction during repairosome assembly ([@bib24], [@bib36]). We determined whether SMARCAD1 was subject to post-translational ubiquitination by immunoprecipitating SMARCAD1 from cell extracts after irradiation followed by western blot analysis with a pan-ubiquitin antibody ([Figure 4](#fig4){ref-type="fig"}A). Significant levels of ubiquitinated SMARCAD1 (ub-SMARCAD1) were not detected in control cells or in cells 0.5 hr post-irradiation. However, 2 hr post-irradiation, ub-SMARCAD1 was easily detectable and still present, but it declined at 3 hr post-irradiation before becoming undetectable at 4 hr. The ubiquitin linkage is mainly K63 ([Figure 4](#fig4){ref-type="fig"}B), although some K48 linkage can be detected particularly 2 hr after irradiation ([Figure 4](#fig4){ref-type="fig"}C) when K63-linked SMARCAD1 has declined ([Figure 4](#fig4){ref-type="fig"}B). This pattern and type of ubiquitination is consistent with a regulatory role early in the DDR and not a degradation function, particularly as there is no change in total cellular SMARCAD1 levels over the time period examined (0--240 min) ([Figures 4](#fig4){ref-type="fig"}A and 4B).Figure 4Ubiquitination of SMARCAD1IR-induced K63-linked ubiquitination of SMARCAD1 by RING1: immunoprecipitation (under denaturing conditions), followed by western blot analysis with the indicated antibodies(A) IR-dependent ubiquitination of SMARCAD1 (pan Ub antibody).(B) IR-induced K63-linked ubiquitination of SMARCAD1.(C) IR-induced SMARCAD1 K48-linked ubiquitination.(D) Mutation of the SMARCAD1 (T906A) ATM phosphorylation site blocks ubiquitination.(E) Mutation of SMARCAD1 lysine 905 (K905R) blocks ubiquitination.(F) Phosphorylation of the SMARCAD1 ubiquitination site (K905R) mutant.(G) BARD1 depletion has no impact on IR-induced SMARCAD1 ubiquitination.(H) IR-induced SMARCAD1 ubiquitination is lost in cells depleted of the E3 Ub ligase RING1.

The K63 ubiquitination of SMARCAD1 at 2 hr post-irradiation ([Figure 4](#fig4){ref-type="fig"}B) was dependent on IR-induced ATM phosphorylation, as the T906A SMARCAD1 mutant was not ubiquitinated ([Figure 4](#fig4){ref-type="fig"}D). SMARCAD1 has a potential ubiquitination site at lysine 905, and K905R mutation led to the loss of IR-induced ubiquitination ([Figure 4](#fig4){ref-type="fig"}E). Initially, K905R is phosphorylated after irradiation, but the phosphorylation does not persist over time (60 min onward) ([Figure 4](#fig4){ref-type="fig"}F). These data suggest that SMARCAD1 ubiquitination is required for the stabilization of SMARCAD1 phosphorylation, which is also supported by our K63 ubiquitination data ([Figure 4](#fig4){ref-type="fig"}B).

The BRCA1-BARD1 complex ubiquitinates histone H2A, and SMARCAD1 binds to H2A-ubiquitin through its two CUE domains, which facilitates localization to DNA damage sites ([@bib10]). However, disruption of the BRCA1-BARD1 complex by BARD1 depletion had no effect on SMARCAD1 ubiquitination ([Figure 4](#fig4){ref-type="fig"}G), suggesting that it is not a BRCA1 substrate. A previous mass-spectrometric analysis of proteins co-immunoprecipitating with SMARCDA1 identified several known E3 ligases including RING1 ([@bib35]). Analysis of potential ligases by siRNA-specific depletion indicated that only RING1 loss correlated with decreased SMARCAD1 ubiquitination ([Figure 4](#fig4){ref-type="fig"}H).

SMARCAD1 Post-translational Modifications Affect Repair Factor Recruitment to DSBs {#sec2.6}
----------------------------------------------------------------------------------

To test the functional consequences of SMARCAD1 ubiquitination status, we analyzed DNA DSB resection in cells depleted of RING1 and in cells expressing the SMARCAD1-K905R mutant that is not ubiquitinated. Resection was reduced both in cells expressing SMARCAD1-K905R and in those depleted of RING1 ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). The failure of SMARCAD1 and RING1 co-depletion to further decrease the level of resection suggests that both act in the same pathway ([Figure S3](#mmc1){ref-type="supplementary-material"}B). These results, together with the additional data described above, suggest that an obligatory, at least two-step series of SMARCD1 post-translational modifications is required for DSB end resection: phosphorylation (ATM) and ubiquitination (RING1).

We determined the importance of post-translational modifications for SMARCAD1 recruitment to l-Scel DSBs by expressing FLAG-tagged wild-type and mutant SMARCAD1 in cells depleted of endogenous SMARCAD1 ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E). The only mutation in a potential ATM phosphorylation site (S132, S302, and T906) that reduced SMARCAD1 accumulation at the DSB was T906A; recruitment to the DSB also was not altered by the SMARCAD1 ATPase mutation K528R ([Figure 5](#fig5){ref-type="fig"}A). Neither SMARCAD1 depletion nor SMARCAD1 mutant expression altered H2AX phosphorylation at DSB sites ([Figure 5](#fig5){ref-type="fig"}B). We also observed that the recruitment of BRCA1 at DSBs was affected, as cells expressing the ATPase mutant (SMARCAD1 K528R), like SMARCAD1 T906A-expressing or SMARCAD1-depleted cells, had significantly reduced BRCA1 levels at DSBs ([Figure 5](#fig5){ref-type="fig"}C). DR95 cells with and without SMARCAD1 depletion were examined for γ-H2AX accumulation at a site-specific DSB induced by l-SceI expression. There was SMARCAD1 co-localization with γ-H2AX foci in cells with SMARCAD1, whereas no co-localization of SMARCAD1 with γ-H2AX foci was observed in SMARCAD1-depleted cells ([Figure 5](#fig5){ref-type="fig"}D). These results are consistent with the ChIP data showing that SMARCAD1 recruits to DSB sites.Figure 5Impact of SMARCAD1 Mutation on Recruitment(A--D) Post-translational modification of SMARCAD1 recruitment to a DSB as well as recruitment of BRCA1: Analysis by ChIP/qPCR demonstrating that (A) SMARCAD1 recruitment to a DSB is blocked by the T906A mutation but not the S32A, S302A, or K528R mutation. (B) Amount of γ-H2AX at the DSB site is unaltered by SMARCAD1 mutant expression. (C) BRCA1 localization at break site is decreased by the T906A and K528R mutations but not the S302A mutation. (D) SMARCAD1 co-localizes with γ--H2X at a unique DSB site induced by ISce1 cleavage. Scale bars shown are 10 um. The mean presented is from three to four experiments (\*\*\*p \< 0.001, as determined by Student\'s t test).

Depletion of RING1 decreased the accumulation of SMARCAD1 at DSBs ([Figure 6](#fig6){ref-type="fig"}A) but had no effect on the accumulation of γ-H2AX at DSBs ([Figure 6](#fig6){ref-type="fig"}B). Consistent with these results, the accumulation of phosphomimetic SMARCAD1 mutant (Flag-SMARCAD1-T906E) was comparable with wild-type SMARCAD1; however, reduced accumulation at DSBs was observed for SMARCAD1 K905R ([Figure 6](#fig6){ref-type="fig"}C). These results suggest that phosphorylation of SMARCAD1 T906 and also ubiquitination are essential for the recruitment of SMARCAD1 to DNA DSBs.Figure 6Impact of RING1 on SMARCAD1 Recruitment(A--C) Impact of RINGI depletion on recruitment of SMARCAD1 at DSB: (A) RING1 depletion affects SMARCAD1 localization at the DSBs. (B) Localization of γ-H2AX at the DSBs in the presence or absence of RING1 siRNA is not affected. (C) Phosphomimetic mutant FLAG-SMARCAD1 T906E goes to the DSBs but not the Ub-specific mutant FLAG-SMARCAD1 K905R. The mean presented is from three to four experiments (\*\*\*p \< 0.001, as determined by Student\'s t test).

SMARCAD1 Depletion or Lack of Post-translational Modifications Increase Cell Killing after Genotoxic Stress {#sec2.7}
-----------------------------------------------------------------------------------------------------------

To determine the contribution of post-translational SMARCAD1 modifications to radiosensitivity, clonogenic cell survival assays were performed ([Figure 7](#fig7){ref-type="fig"}A). Depletion of SMARCAD1 decreased H1299 cell survival after irradiation but had no additional impact on survival of ATM-deficient (AT-5) cells, suggesting that SMARCAD1 and ATM act in the same repair pathway. Depletion of RING1 with siRNA also decreased the post-irradiation cell survival, but depletion of both RING1 and SMARCAD1 had no additional impact on cell survival ([Figure 7](#fig7){ref-type="fig"}B), also indicating a common pathway. Decreased survival was also observed in SMARCAD1-depleted cells after cisplatin treatment ([Figure 7](#fig7){ref-type="fig"}C). Cells expressing either SMARCAD1 T906A or SMARCAD1 K528R also had decreased survival following irradiation, at levels similar to those of SMARCAD1-depleted cells ([Figure 7](#fig7){ref-type="fig"}D).Figure 7SMARCAD1 Phosphorylation and Ubiquitination Contributes to Cell Survival and DNA Damage Repair by HR(A) Clonogenic survival in cells with and without SMARCAD1 depletion after IR treatment and when compared with ATM-deficient (AT-5) cells.(B) Decreased survival of RING1-depleted cells after IR treatment.(C) Decreased survival of SMARCAD1-depleted cells after cisplatin treatment, clonogenic survival.(D) Expression of T906A, K528R, or K905R decreases cell survival after IR (1 Gy) but not S132A or S302A.(E) SMARCAD1 depletion does not alter GFP-based NHEJ repair.(F) Loss of SMARCAD1, or expression of T906A, K528R, or K905R, decreases DSB repair by HR, DR-GFP-based HR assay. DR, direct repeats.(G) Cells depleted of SMARCAD1 or expressing Flag-T907A have increased S-phase-specific chromosome aberrations, as indicated by the presence of radials, breaks, and gaps, both constitutively and after irradiation.(H) Cells depleted of SMARCAD1 or expressing Flag-T906A have increased metaphase chromosome aberrations both constitutively and after treatment with cisplatin.(I) Sister chromatid exchanges (SCEs) increase in cells depleted of SMARCAD1 or expressing Flag-T906A in the presence or absence of cisplatin. The mean presented is from three to four experiments (\*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001 as determined by Student\'s t test).

Next we tested the effect of SMARCAD1 mutations on the efficiency of DSB repair by using standard GFP gene reporter l-Scel-inducible assays ([@bib13]). Cells depleted for SMARCAD1 did not show any significant defect in DSB repair by NHEJ ([Figure 7](#fig7){ref-type="fig"}E). In contrast, cells depleted of endogenous SMARCAD1 had significantly decreased HR repair, which was not restored by expression of either SMARCAD1 T906A or SMARCAD1 K528R but was restored by exogenous wild-type or SMARCAD1 T906E expression ([Figure 7](#fig7){ref-type="fig"}F). These data suggest that ATM-mediated phosphorylation of SMARCAD1 at T906, as well as SMARCAD1 ATPase activity, are required for efficient DNA DSB repair by the HR pathway.

Role of SMARCAD1 Modifications in S-Phase-Specific Chromosome Repair {#sec2.8}
--------------------------------------------------------------------

We measured the level of IR-induced G1-, S-, and G2-phase-specific chromosomal aberrations in exponentially growing cells ([Figures S4](#mmc1){ref-type="supplementary-material"}A, S4B, and S4C) and observed an increase in SMARCAD1-depleted cells ([Figure S4](#mmc1){ref-type="supplementary-material"}D). The results described above indicated that SMARCAD1 depletion or mutation affected DNA DSB resection during HR-mediated repair, a largely S-phase cell-specific pathway. Therefore we analyzed chromosome aberrations in each specific cell phase. SMARCAD1-depleted cells had higher levels of IR-induced S-phase-specific chromosome aberrations ([Figure 7](#fig7){ref-type="fig"}G), whereas G1- and G2-phase aberrations were similar to those of control cells ([Figures S4](#mmc1){ref-type="supplementary-material"}E and S4F), supporting the model that SMARCAD1 is not involved in DSB repair in G1-phase where NHEJ is the predominant repair. These results are consistent with DNA DSB end joining assay ([Figure 7](#fig7){ref-type="fig"}E). In addition, cells depleted for SMACAD1 but expressing SMARCAD1 T906A also had a high frequency of IR-induced S-phase aberrations ([Figure 7](#fig7){ref-type="fig"}G). Similarly, cisplatin treatment induced a higher frequency of chromosome aberrations in cells depleted of SMARCAD1 or expressing SMARCAD1 T906A than in control cells ([Figure 7](#fig7){ref-type="fig"}H). These results are consistent with an S-phase role for SMARCAD1, where HR repair is the predominant mode of DNA repair. Furthermore, we found that even in the absence of induced DNA damage, SMARCAD1-depleted cells had elevated levels of spontaneous sister chromatid exchanges (SCEs), which was further enhanced upon cisplatin treatment ([Figures S4](#mmc1){ref-type="supplementary-material"}G, S4H, and [7](#fig7){ref-type="fig"}I). This possibly indicates hyper-recombination or increased crossover as previously observed in yeast ([@bib5], [@bib44]) and in BLM helicase-deficient human cells ([@bib46]).

Discussion {#sec3}
==========

SMARCAD1 has been reported to play a role in the DSB end resection step required for subsequent loading of checkpoint and repair proteins during DNA damage repair ([@bib5], [@bib6], [@bib8]). In this study, we demonstrate the role and complex regulatory pattern for SMARCAD1 in multiple steps of HR-mediated DNA repair. During the process of DSB repair, chromatin structure influences the docking of signaling and repair proteins. Our data provide insight into this mechanism in that DNA damage induces SMARCAD1 phosphorylation by ATM, promoting a cascade of HR repair functions where SMARCAD1 is directly involved.

DNA end resection in eukaryotes is a two-step process ([@bib12], [@bib25]). To initiate DNA end resection, the first step is to displace 53BP1 by BRCA1 ([@bib17]). Our results suggest that SMARCAD1 works early in the resection pathway along with ATM and therefore its role differs from the yeast ortholog Fun30, which is needed primarily for the extensive resection mediated by Exo1 or Sgs1 ([@bib5], [@bib8]). It has been reported that SMARCAD1 is a substrate of ATM ([@bib10], [@bib23]). We report here that the post-translational phosphorylation of the highly conserved T906Q motif is a key to SMARCAD1 function in DNA end resection and DSB repair by the HR pathway. Phosphorylation at this site was not detected in the previous studies ([@bib5], [@bib8], [@bib10]), which detected only Ser132 and Ser302 phosphorylation ([@bib23]). The ER-AsiSI DNA resection system that we utilized has limitations in measuring long-range resection beyond 3.5 Kb, not reaching the 5--10 Kb resection range. Our results, however, suggest that SMARCAD1 is involved in short-range resection.

We have demonstrated that SMARCAD1 facilitates the recruitment of BRCA1 at the DNA break site and that SMARCAD1 phosphorylation at T906 and its ATPase activity are required for BRCA1 localization at break sites. Recent studies have shown that BRCA1-BARD1 ligase activity modifies chromatin, which affects the accumulation of SMARCAD1 and the repositioning of 53BP1 to allow for resection completion ([@bib10]). Disruption of the BRCA1-BARD1 complex by depleting BARD1, which is an E3 ligase, did not affect SMARCAD1 ubiquitination, and we instead identified RING1 as the potential SMARCAD1 E3 ligase that modifies K905. Loss of RING1 abolishes SMARCAD1 ubiquitination and affects its function during DNA end resection and cell survival, suggesting that both act in the same pathway with SMARCAD1 as a substrate downstream of RING1. These findings are an addition to the previously known functions of RING1 during DNA damage signaling, ubiquitination of H2A at K118 and K119 ([@bib4], [@bib39]). Our data suggest that coincident phosphorylation and ubiquitination stabilizes SMARCAD1 (2 hr post-irradiation), contributing to the process of BRCA1 localization at the break site by replacing 53BP1. We also find that the post-translational modification of SMARCAD1 is essential to carry out additional steps in HR repair since specific combinations of SMARCAD1 post-translational modifications allow binding of DNA repair factors and healing of the DNA lesion. Immunofluorescence data and ChIP data are consistent with a model in which SMARCAD1 interacts with and facilitates BRCA1 displacement of 53BP1 from DSB sites.

In conclusion, our findings reveal that the recruitment of SMARCAD1 to DSB sites is ATM dependent as shown in the graphic model ([Figure 8](#fig8){ref-type="fig"}), thus SMARCAD1 is an upstream DDR fidelity protein. SMARCAD1 is subject to IR-induced post-translational modifications carried out by ATM kinase and RING1 E3 ligase, both of which are important for proper DSB end resection. These SMARCAD1 post-translational modifications then affect downstream events in HR-mediated DNA repair, and their loss ultimately contributes to decreased HR and cell survival after genotoxic injury.Figure 8SMARCAD1 Post-translational Modifications Impact DNA ResectionModel Showing SMARCAD1 Regulation during Repair: ATM-dependent phosphorylation and RING1-dependent ubiquitination of SMARCAD1 helicase regulates the DNA end resection step of repair by homologous recombination.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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========================

Document S1. Transparent Methods and Figures S1--S4
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